The Ongoing Challenges of Targeting the Androgen Receptor

被引：5
作者：
Kolinsky, Michael [1 ,2 ]
de Bono, Johann S. [1 ,2 ]
机构：
[1] Inst Canc Res, London SW3 6JB, England
[2] Royal Marsden NHS Fdn Trust, London, England
来源：
EUROPEAN UROLOGY | 2016年 / 69卷 / 05期
关键词：
RESISTANT PROSTATE-CANCER; PLUS PREDNISONE; DOUBLE-BLIND; CASTRATION; ABIRATERONE; TRIAL; ENZALUTAMIDE; MULTICENTER; DOCETAXEL;
D O I：
10.1016/j.eururo.2015.10.052
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：841 / 843
页数：3
相关论文
共 50 条
  • [41] Current androgen receptor antagonists under investigation for resistant prostate cancer
    Nigro, Maria Concetta
    Mollica, Veronica
    Marchetti, Andrea
    Cheng, Michael
    Rosellini, Matteo
    Montironi, Rodolfo
    Cheng, Liang
    Massari, Francesco
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (02) : 191 - 202
  • [42] Developing new targeting strategy for androgen receptor variants in castration resistant prostate cancer
    Wang, Bin
    Lo, U-Ging
    Wu, Kaijie
    Kapur, Payal
    Liu, Xiangyang
    Huang, Jun
    Chen, Wei
    Hernandez, Elizabeth
    Santoyo, John
    Ma, Shi-Hong
    Pong, Rey-Chen
    He, Dalin
    Cheng, Yi-Qiang
    Hsieh, Jer-Tsong
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (10) : 2121 - 2130
  • [43] Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer
    Lv, Shidong
    Song, Qiong
    Chen, Guang
    Cheng, Erdong
    Chen, Wei
    Cole, Ryan
    Wu, Zeyu
    Pascal, Laura E.
    Wang, Ke
    Wipf, Peter
    Nelson, Joel B.
    Wei, Qiang
    Huang, Wenhua
    Wang, Zhou
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (04)
  • [44] Prostate Cancer Characteristics Associated with Response to Pre-Receptor Targeting of the Androgen Axis
    Mostaghel, Elahe A.
    Morgan, Andrew
    Zhang, Xiaotun
    Marck, Brett T.
    Xia, Jing
    Hunter-Merrill, Rachel
    Gulati, Roman
    Plymate, Stephen
    Vessella, Robert L.
    Corey, Eva
    Higano, Celestia S.
    Matsumoto, Alvin M.
    Montgomery, R. Bruce
    Nelson, Peter S.
    PLOS ONE, 2014, 9 (10):
  • [45] Targeting castration-resistant prostate cancer with androgen receptor antisense oligonucleotide therapy
    De Velasco, Marco A.
    Kura, Yurie
    Sakai, Kazuko
    Hatanaka, Yuji
    Davies, Barry R.
    Campbell, Hayley
    Klein, Stephanie
    Kim, Youngsoo
    MacLeod, A. Robert
    Sugimoto, Koichi
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    JCI INSIGHT, 2019, 4 (17)
  • [46] Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting
    Antonarakis, E. S.
    Armstrong, A. J.
    Dehm, S. M.
    Luo, J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2016, 19 (03) : 231 - 241
  • [47] Androgen deprivation therapy plus chemotherapy ± androgen receptor-targeting agents for metastatic hormone-sensitive prostate cancer
    Wenzel, Mike
    Hoeh, Benedikt
    Chun, Felix K. H.
    Mandel, Philipp
    UROLOGIE, 2023, 62 (04): : 360 - 368
  • [48] Discovery of novel antagonists targeting the DNA binding domain of androgen receptor by integrated docking-based virtual screening and bioassays
    Pang, Jin-ping
    Shen, Chao
    Zhou, Wen-fang
    Wang, Yun-xia
    Shan, Lu-hu
    Chai, Xin
    Shao, Ying
    Hu, Xue-ping
    Zhu, Feng
    Zhu, Dan-yan
    Xiao, Li
    Xu, Lei
    Xu, Xiao-hong
    Li, Dan
    Hou, Ting-jun
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (01) : 229 - 239
  • [49] Intracellular kinetics of the androgen receptor shown by multimodal Image Correlation Spectroscopy (mICS)
    Chiu, Chi-Li
    Patsch, Katherin
    Cutrale, Francesco
    Soundararajan, Anjana
    Agus, David B.
    Fraser, Scott E.
    Ruderman, Daniel
    SCIENTIFIC REPORTS, 2016, 6
  • [50] Targeting the androgen receptor in triple-negative breast cancer
    Gucalp, Ayca
    Traina, Tiffany A.
    CURRENT PROBLEMS IN CANCER, 2016, 40 (2-4) : 141 - 150
12345